United States: Decision Diagnostics Saga Continues As Investors Bring Suit - Proskauer Rose LLP
Published
In December, the SEC filed a complaint against Decision Diagnostics and its CEO, Keith Berman, for falsely claiming the company had developed a finger prick blood test that could instantaneously...
Full Article